Purchase Order 75N95C25P00096
Award Date 9/4/25
Potential Completion Date 9/3/26
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94063, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Center for Advancing Translational Sciences (NCATS), a civilian agency, awarded a $35,000.00 firm fixed price purchase order contract to Editco Bio Inc., a self-certified small disadvantaged business. The contract, with an ultimate completion date of December 17, 2024, is for the product SYNTHEGO:1293873 [24-007185]. The contract does not have a set-aside designation.</p>
- <p>The National Center for Advancing Translational Sciences (NCATS) awarded a purchase order to Cellecta, Inc. on May 11, 2026, for $19,185.00 to develop custom knock-in cell lines. Work is performed in Mountain View, California. The order is firm fixed price with no small business set-aside. Ultimate completion is scheduled for May 10, 2027.</p>
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,512.25 firm fixed-price purchase order to Life Technologies Corporation of Carlsbad, California. As the prime contractor, Life Technologies will provide products or services to NIH NCATS between August 31 and October 1, 2023. The award is not associated with a multiple award contract vehicle. No subcontractors or set aside designations were indicated....
- This federal contract award, valued at $22,825.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH). The contract was awarded to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products based in Redwood City, California. The contract is for the delivery of KNOCKIN-SMALL, CELL CLONE, IPSC, SYNTHEGO SUPPLIED services, which likely support NCATS'...
- The National Heart Lung and Blood Institute, a civilian federal agency, awarded a $11,450.00 firm-fixed-price purchase order to Editco Bio Inc., a self-certified small disadvantaged business, to provide knock-in cell line generation services to support Dr. Martina's cell biology experiments. The contract has an ultimate completion date of December 26, 2024 and was awarded on August 29, 2024. This contract award is not associated with a larger vehicle and does not have a set-aside designation.
- The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $240,000.00 firm fixed-price purchase order to Chemogenics Biopharma, LLC, a for-profit limited liability company, for custom synthesis and bioanalytical services to support NCATS' internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases. The 12-month contract is not set aside and is awarded under FAR Part 13 simplified...
- The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), awarded a $99,000 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to independently provide services to obtain kinases' percent inhibition for 5,000 data points at one concentration and 400 IC50 curves of malaria compounds. This non-competitive acquisition leverages Life Technologies' specialized expertise in...
- The National Center for Advancing Translational Sciences (NCATS), acting through the National Institute on Drug Abuse (NIDA), awarded a $90,000 firm fixed-price purchase order to Proteintech Group, Inc. (UEI: JM5GFF72S7X6) on September 22, 2025, for Human Discovery Panel (HDP) analysis to obtain single-cell multiomic data. The contract, which will be performed in Rosemont, Illinois, is scheduled for completion by September 21, 2026. This award follows a pre-solicitation market research notice...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price purchase order contract worth $265,048.50 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of assorted cell culture medium, substrate, and supplements manufactured by Life Technologies. This contract supports the Stem Cell Translation Laboratory within the National...
- The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), awarded a $23,940.00 firm-fixed-price purchase order to Life Technologies Corporation, a division of Thermo Fisher Scientific, for a View RNA in situ hybridization (ISH) cell assay kit. This acquisition supports NCATS' Cooperative Research and Development Agreement (CRADA) for Alagille syndrome (ALGS) research, specifically to screen compound libraries for activators of the...